Form 4 holding
Acting Chief Medical Officer
Monopar Therapeutics
- Security class
- Stock Option
- Shares / value
- 2,000
- Estimated value
- Report date
- 01 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount